The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
1847 GOEDEKER INC | *W EXP 06/02/202 | 28252C117 | 3,778 | 6,103,824 | SH | SOLE | 6,103,824 | 0 | 0 | ||
2SEVENTY BIO INC | COMMON STOCK | 901384107 | 1,962 | 115,000 | SH | SOLE | 115,000 | 0 | 0 | ||
ACHIEVE LIFE SCIENCES INC | COM | 004468500 | 924 | 122,000 | SH | SOLE | 122,000 | 0 | 0 | ||
ADICET BIO INC | COM | 007002108 | 3,095 | 155,000 | SH | SOLE | 155,000 | 0 | 0 | ||
ADMA BIOLOGICS INC | COM | 000899104 | 6,039 | 3,300,000 | SH | SOLE | 3,300,000 | 0 | 0 | ||
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 1,927 | 66,196 | SH | SOLE | 66,196 | 0 | 0 | ||
ALTIMMUNE INC | COM NEW | 02155H200 | 1,961 | 322,000 | SH | SOLE | 322,000 | 0 | 0 | ||
ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 980 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
AULT DISRUPTIVE TECHS CORP | *W EXP 99/99/999 | 05150A112 | 19 | 112,500 | SH | SOLE | 112,500 | 0 | 0 | ||
AULT DISRUPTIVE TECHS CORP | COM | 05150A104 | 1,496 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 4,488 | 243,000 | SH | SOLE | 243,000 | 0 | 0 | ||
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 987 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 9,976 | 1,450,006 | SH | SOLE | 1,450,006 | 0 | 0 | ||
BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | 5,266 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
CALITHERA BIOSCIENCES INC | COM | 13089P101 | 82 | 202,276 | SH | SOLE | 202,276 | 0 | 0 | ||
CARA THERAPEUTICS INC | COM | 140755109 | 2,005 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | ||
CEA INDUSTRIES INC | *W EXP 02/11/202 | 86887P119 | 171 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 2,248 | 66,000 | SH | SOLE | 66,000 | 0 | 0 | ||
CHAVANT CAPITAL ACQUISITN CO | ORDINARY SHARES | G2058L103 | 1,982 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
CHAVANT CAPITAL ACQUISITN CO | *W EXP 99/99/999 | G2058L111 | 30 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 8,916 | 545,000 | SH | SOLE | 545,000 | 0 | 0 | ||
CINGULATE INC | *W EXP 12/03/202 | 17248W113 | 108 | 270,000 | SH | SOLE | 270,000 | 0 | 0 | ||
COLISEUM ACQUISITION CORP | CLASS A ORD SHS | G2263T123 | 825 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
COLISEUM ACQUISITION CORP | *W EXP 08/22/202 | G2263T107 | 10 | 28,333 | SH | SOLE | 28,333 | 0 | 0 | ||
COLOMBIER ACQUISITION CORP | CL A | 19533H108 | 484 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
COLOMBIER ACQUISITION CORP | *W EXP 99/99/999 | 19533H116 | 5 | 16,666 | SH | SOLE | 16,666 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 4,478 | 204,000 | SH | SOLE | 204,000 | 0 | 0 | ||
CTI BIOPHARMA CORP | COM | 12648L601 | 1,400 | 299,800 | SH | SOLE | 299,800 | 0 | 0 | ||
CURIS INC | COM NEW | 231269200 | 1,287 | 540,800 | SH | SOLE | 540,800 | 0 | 0 | ||
CUTERA INC | COM | 232109108 | 1,035 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 5,443 | 1,750,000 | SH | SOLE | 1,750,000 | 0 | 0 | ||
CYTOMX THERAPEUTICS INC | COM | 23284F105 | 1,772 | 663,800 | SH | SOLE | 663,800 | 0 | 0 | ||
DEXCOM INC | COM | 252131107 | 6,395 | 12,500 | SH | SOLE | 12,500 | 0 | 0 | ||
DIGITAL HEALTH ACQUISITION C | UNIT 11/02/2026 | 253893200 | 1,515 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
DIRECT DIGITAL HOLDINGS INC | *W EXP 02/15/202 | 25461T113 | 131 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
DOUBLEDOWN INTERACTIVE CO LT | ADS | 25862B109 | 722 | 60,876 | SH | SOLE | 60,876 | 0 | 0 | ||
EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 3,652 | 440,000 | SH | SOLE | 440,000 | 0 | 0 | ||
ENVISTA HOLDINGS CORPORATION | COM | 29415F104 | 5,115 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 11,584 | 2,496,524 | SH | SOLE | 2,496,524 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | SHS | G3141W106 | 3,936 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | *W EXP 10/23/202 | G3141W122 | 25 | 133,333 | SH | SOLE | 133,333 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 2,728 | 224,541 | SH | SOLE | 224,541 | 0 | 0 | ||
FAT BRANDS INC | *W EXP 07/16/202 | 30258N121 | 1,022 | 227,000 | SH | SOLE | 227,000 | 0 | 0 | ||
GIGINTERNATIONAL1 INC | *W EXP 04/19/202 | 37518W114 | 18 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
GIGINTERNATIONAL1 INC | COM | 37518W106 | 2,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
GLAUKOS CORP | COM | 377322102 | 5,435 | 94,000 | SH | SOLE | 94,000 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 1,871 | 54,000 | SH | SOLE | 54,000 | 0 | 0 | ||
GLOBUS MED INC | CL A | 379577208 | 5,829 | 79,000 | SH | SOLE | 79,000 | 0 | 0 | ||
GSR II METEORA ACQUISITN COR | UNIT 02/24/2027 | 36263W204 | 506 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
HARBOR CUSTOM DEVELOPMENT IN | *W EXP 05/09/202 | 41150T116 | 171 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
HARBOR CUSTOM DEVELOPMENT IN | *W EXP 10/04/202 | 41150T124 | 240 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 99 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
HILLMAN SOLUTIONS CORP | COM | 431636109 | 2,328 | 196,000 | SH | SOLE | 196,000 | 0 | 0 | ||
ILLUMINA INC | COM | 452327109 | 3,843 | 11,000 | SH | SOLE | 11,000 | 0 | 0 | ||
IMMATICS N.V | *W EXP 07/01/202 | N44445117 | 171 | 97,467 | SH | SOLE | 97,467 | 0 | 0 | ||
IMMUNIC INC | COM | 4525EP101 | 3,390 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
IMMUNOGEN INC | COM | 45253H101 | 4,379 | 920,000 | SH | SOLE | 920,000 | 0 | 0 | ||
INDUSTRIAL HUMAN CAPITAL INC | COM | 45617P104 | 1,002 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
INDUSTRIAL HUMAN CAPITAL INC | *W EXP 11/27/202 | 45617P112 | 18 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 6,298 | 268,000 | SH | SOLE | 268,000 | 0 | 0 | ||
INSPIRE MED SYS INC | COM | 457730109 | 4,107 | 16,000 | SH | SOLE | 16,000 | 0 | 0 | ||
INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 1,377 | 22,500 | SH | SOLE | 22,500 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 3,972 | 236,000 | SH | SOLE | 236,000 | 0 | 0 | ||
JIYA ACQUISITION CORP | COM CL A | 47760M102 | 1,966 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 2,663 | 21,000 | SH | SOLE | 21,000 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 4,754 | 645,000 | SH | SOLE | 645,000 | 0 | 0 | ||
KEROS THERAPEUTICS INC | COM | 492327101 | 6,852 | 126,000 | SH | SOLE | 126,000 | 0 | 0 | ||
LAKESHORE ACQUISITION I CORP | *W EXP 07/15/202 | G53521111 | 53 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
LAKESHORE ACQUISITION I CORP | ORDINARY SHARES | G53521103 | 1,982 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
LANTHEUS HLDGS INC | COM | 516544103 | 2,212 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
LIGHTNING EMOTORS INC | *W EXP 05/18/202 | 53228T119 | 268 | 652,173 | SH | SOLE | 652,173 | 0 | 0 | ||
LIVANOVA PLC | SHS | G5509L101 | 4,092 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
MORPHIC HLDG INC | COM | 61775R105 | 2,409 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
MURPHY CANYON ACQUISITION CO | UNIT 01/25/2027 | 626642201 | 1,010 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
MUSCLE MAKER INC | COM | 627333107 | 948 | 1,796,961 | SH | SOLE | 1,796,961 | 0 | 0 | ||
MYRIAD GENETICS INC | COM | 62855J104 | 2,891 | 114,710 | SH | SOLE | 114,710 | 0 | 0 | ||
NEVRO CORP | COM | 64157F103 | 5,569 | 77,000 | SH | SOLE | 77,000 | 0 | 0 | ||
NEXGEL INC | *W EXP 12/01/202 | 65344E115 | 88 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
NLS PHARMACEUTICS LTD | *W EXP 09/25/202 | H57830111 | 76 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
NOCTURNE ACQUISITION CORP | ORDINARY SHARES | G6580S114 | 5,040 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
NOCTURNE ACQUISITION CORP | RIGHT 12/26/2025 | G6580S106 | 105 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 3,440 | 695,000 | SH | SOLE | 695,000 | 0 | 0 | ||
OMEGA ALPHA SPAC | CL A | G6749V107 | 982 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
OPY ACQUISITION CORP I | COM CL A | 671005106 | 980 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
OPY ACQUISITION CORP I | *W EXP 09/22/202 | 671005114 | 20 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
OUTSET MED INC | COM | 690145107 | 2,361 | 52,007 | SH | SOLE | 52,007 | 0 | 0 | ||
PARDES BIOSCIENCES INC | COM | 69945Q105 | 1,827 | 253,000 | SH | SOLE | 253,000 | 0 | 0 | ||
PEPPERLIME HEALTH ACQUSTN CO | UNIT 99/99/9999 | G70021129 | 7,232 | 735,000 | SH | SOLE | 735,000 | 0 | 0 | ||
PEPPERLIME HEALTH ACQUSTN CO | *W EXP 10/01/202 | G70021111 | 152 | 367,500 | SH | SOLE | 367,500 | 0 | 0 | ||
PROCEPT BIOROBOTICS CORP | COM | 74276L105 | 1,647 | 47,077 | SH | SOLE | 47,077 | 0 | 0 | ||
PROFOUND MED CORP | COM NEW | 74319B502 | 1,125 | 124,945 | SH | SOLE | 124,945 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 11,840 | 5,000 | SH | Call | SOLE | 5,000 | 0 | 0 | |
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 9,140 | 386,000 | SH | SOLE | 386,000 | 0 | 0 | ||
QIAGEN NV | SHS NEW | N72482123 | 4,557 | 93,000 | SH | SOLE | 93,000 | 0 | 0 | ||
QUIDEL CORP | COM | 74838J101 | 6,298 | 56,000 | SH | SOLE | 56,000 | 0 | 0 | ||
RELATIVITY ACQUISITION CORP | UNIT 02/10/2027 | 75944B205 | 1,007 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
RELMADA THERAPEUTICS INC | COM | 75955J402 | 5,560 | 206,000 | SH | SOLE | 206,000 | 0 | 0 | ||
RENOVACOR INC | COM | 75989E106 | 1,649 | 388,845 | SH | SOLE | 388,845 | 0 | 0 | ||
RENOVACOR INC | *W EXP 99/99/999 | 75989E114 | 249 | 731,561 | SH | SOLE | 731,561 | 0 | 0 | ||
REPRO MED SYS INC | COM | 759910102 | 2,847 | 995,500 | SH | SOLE | 995,500 | 0 | 0 | ||
SARISSA CAPITAL ACQUISITN CO | CL A | G7823W102 | 2,228 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
SARISSA CAPITAL ACQUISITN CO | *W EXP 10/23/202 | G7823W110 | 27 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
SHOCKWAVE MED INC | COM | 82489T104 | 4,769 | 23,000 | SH | SOLE | 23,000 | 0 | 0 | ||
SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | 2,071 | 109,000 | SH | SOLE | 109,000 | 0 | 0 | ||
SOMALOGIC INC | CLASS A COM | 83444K105 | 1,444 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
SURGEPAYS INC | *W EXP 10/22/202 | 86882L113 | 223 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
SURROZEN INC | *W EXP 08/01/203 | 86889P117 | 21 | 82,233 | SH | SOLE | 82,233 | 0 | 0 | ||
TAILWIND ACQUISITION CORP | COM CL A | 87403Q102 | 1,271 | 128,414 | SH | SOLE | 128,414 | 0 | 0 | ||
TANDEM DIABETES CARE INC | COM NEW | 875372203 | 5,815 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
TC BIOPHARM HOLDINGS PLC | *W EXP 02/08/202 | 87807D111 | 461 | 941,176 | SH | SOLE | 941,176 | 0 | 0 | ||
TG VENTURE ACQUISITION CORP | UNIT 08/15/2028 | 87251T208 | 2,004 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
TURMERIC ACQUISITION CORP | *W EXP 10/08/202 | G9127T124 | 24 | 84,666 | SH | SOLE | 84,666 | 0 | 0 | ||
TURMERIC ACQUISITION CORP | CL A | G9127T108 | 2,502 | 254,000 | SH | SOLE | 254,000 | 0 | 0 | ||
VERASTEM INC | COM | 92337C104 | 4,161 | 2,951,000 | SH | SOLE | 2,951,000 | 0 | 0 | ||
VERRICA PHARMACEUTICALS INC | COM | 92511W108 | 794 | 97,887 | SH | SOLE | 97,887 | 0 | 0 | ||
VIQ SOLUTIONS INC | COM NEW | 91825V400 | 798 | 489,417 | SH | SOLE | 489,417 | 0 | 0 | ||
WESTERN ACQSTN VENTURES CORP | UNIT 09/01/2026 | 95758L206 | 1,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
XTANT MED HLDGS INC | COM NEW | 98420P308 | 4,247 | 6,246,291 | SH | SOLE | 6,246,291 | 0 | 0 |